1
00:00:00,240 --> 00:00:02,720
Imagine this. You're at the Swiss Hotel in

2
00:00:02,720 --> 00:00:06,399
Chicago surrounded by top executives from leading insurance

3
00:00:06,399 --> 00:00:08,099
companies and health systems.

4
00:00:08,480 --> 00:00:12,160
Welcome to Becker's Fall Pair Issues Roundtable, November

5
00:00:12,160 --> 00:00:13,859
4th through 6, 2024.

6
00:00:14,625 --> 00:00:17,345
Picture the excitement as you gather business cards

7
00:00:17,345 --> 00:00:20,005
from over 500 executive level attendees,

8
00:00:20,545 --> 00:00:22,164
building invaluable connections.

9
00:00:22,704 --> 00:00:25,345
Feel the energy as you participate in over

10
00:00:25,345 --> 00:00:29,285
26 educational sessions led by 90 elite speakers.

11
00:00:29,769 --> 00:00:32,969
Envision yourself engaging in lively discussions about new

12
00:00:32,969 --> 00:00:36,409
health plans, hospital at home models, behavioral health,

13
00:00:36,409 --> 00:00:37,549
and price transparency.

14
00:00:38,170 --> 00:00:41,690
Now imagine being inspired by keynotes from boxing

15
00:00:41,690 --> 00:00:45,045
legend, Sugar Ray Leonard, and 4 time NBA

16
00:00:45,184 --> 00:00:47,744
All Star, Chris Webber. Their stories will leave

17
00:00:47,744 --> 00:00:50,004
you motivated and ready to innovate.

18
00:00:50,384 --> 00:00:53,024
Don't miss out on this unique opportunity. Get

19
00:00:53,024 --> 00:00:55,204
registered today. Visit beckershospital

20
00:01:03,759 --> 00:01:05,700
events page. See you in Chicago.

21
00:01:06,319 --> 00:01:08,560
Hello, everyone. This is Jacob Emerson with the

22
00:01:08,560 --> 00:01:10,259
Becker's Payer Issues podcast.

23
00:01:10,754 --> 00:01:13,075
Thrilled today to be joined by a special

24
00:01:13,075 --> 00:01:16,834
guest. Cronos Manolis is the chief pharmacy officer

25
00:01:16,834 --> 00:01:19,634
at UPMC Health Plan. Cronos, thank you so

26
00:01:19,634 --> 00:01:21,394
much for taking the time to sit down

27
00:01:21,394 --> 00:01:22,774
with us on the podcast today.

28
00:01:23,120 --> 00:01:23,700
Thanks, Jacob.

29
00:01:24,480 --> 00:01:26,560
So, Cronos, before we dive into everything that

30
00:01:26,560 --> 00:01:28,079
we wanna talk with you about, can you

31
00:01:28,079 --> 00:01:29,939
tell us a little bit more about yourself,

32
00:01:30,079 --> 00:01:32,159
your background in health care, and what it

33
00:01:32,159 --> 00:01:34,239
is that you're doing today at UPMC Health

34
00:01:34,239 --> 00:01:34,739
Plan?

35
00:01:35,584 --> 00:01:36,225
Yeah. So,

36
00:01:36,704 --> 00:01:39,125
pharmacist by education, been in the business,

37
00:01:39,584 --> 00:01:42,245
for lots lots of years, really within,

38
00:01:42,704 --> 00:01:44,864
all the pharmacy channels. So I've worked in

39
00:01:44,864 --> 00:01:46,004
specialty pharmacy,

40
00:01:46,385 --> 00:01:47,844
worked in retail pharmacy,

41
00:01:48,704 --> 00:01:49,765
worked at a PBM,

42
00:01:50,819 --> 00:01:52,200
and, for the past,

43
00:01:52,579 --> 00:01:54,040
almost 19 years,

44
00:01:54,340 --> 00:01:55,400
worked here at UPMC,

45
00:01:56,260 --> 00:01:59,140
where I, am the chief pharmacy officer of

46
00:01:59,299 --> 00:02:01,400
been really responsible for all things,

47
00:02:01,859 --> 00:02:03,719
on the pharmacy service line.

48
00:02:04,555 --> 00:02:07,194
Fantastic. So a long career in in health

49
00:02:07,194 --> 00:02:09,134
care and and a long one at UPMC

50
00:02:09,514 --> 00:02:10,014
specifically.

51
00:02:11,354 --> 00:02:13,834
In that vein, Kronos, can you hoping to

52
00:02:13,834 --> 00:02:15,194
talk with you a little bit about your

53
00:02:15,194 --> 00:02:16,259
perspective on

54
00:02:16,659 --> 00:02:19,319
the pharmacy and drug access landscape

55
00:02:19,780 --> 00:02:21,459
right now. There's obviously there's so much we

56
00:02:21,459 --> 00:02:24,599
could talk about from the federal level and

57
00:02:24,659 --> 00:02:27,000
things like Medicare negotiation powers,

58
00:02:28,180 --> 00:02:30,875
and access issues to on the private side

59
00:02:30,875 --> 00:02:32,954
in terms of GLP ones right now. It's

60
00:02:32,954 --> 00:02:35,514
obviously a hot topic within the pharmacy space

61
00:02:35,514 --> 00:02:37,694
and the costs and access issues there.

62
00:02:38,074 --> 00:02:40,715
So from your role as as chief pharmacy

63
00:02:40,715 --> 00:02:43,034
officer, can you give us a 30,000 foot

64
00:02:43,034 --> 00:02:45,930
level view of where you view pharmacy

65
00:02:46,390 --> 00:02:48,250
and drug access issues

66
00:02:48,629 --> 00:02:49,129
today?

67
00:02:50,230 --> 00:02:52,310
Yeah. So, you know, you framed it right,

68
00:02:52,310 --> 00:02:55,849
Jacob. There is tons of complexity in pharmacy

69
00:02:55,909 --> 00:02:57,689
today, and we could we could do,

70
00:02:58,310 --> 00:02:59,849
a number of these. Right?

71
00:03:00,504 --> 00:03:02,044
And, you know, from my perspective,

72
00:03:02,344 --> 00:03:04,185
you've said it. Right? I've had a long

73
00:03:04,185 --> 00:03:06,185
career, and I have never seen the kind

74
00:03:06,185 --> 00:03:07,004
of complexity

75
00:03:07,305 --> 00:03:09,705
and attention that pharmacy is getting. I really

76
00:03:09,705 --> 00:03:11,405
believe it's reached its apex.

77
00:03:11,944 --> 00:03:13,784
If you think about it, I have seen

78
00:03:13,784 --> 00:03:14,284
more

79
00:03:14,900 --> 00:03:16,280
headlines about health,

80
00:03:16,819 --> 00:03:18,040
insurers struggling

81
00:03:18,819 --> 00:03:20,120
with their costs,

82
00:03:20,580 --> 00:03:22,740
but drug being one of the top three

83
00:03:22,740 --> 00:03:24,979
reasons that really has never happened in the

84
00:03:24,979 --> 00:03:26,919
past, and it's almost, like, repetitive.

85
00:03:27,780 --> 00:03:29,319
But if you think about it,

86
00:03:29,844 --> 00:03:31,064
we've got a pipeline

87
00:03:31,525 --> 00:03:34,164
that is gonna hold promise for drugs that

88
00:03:34,164 --> 00:03:35,944
we've we've never seen before,

89
00:03:36,245 --> 00:03:37,944
onetime cures, etcetera.

90
00:03:38,564 --> 00:03:41,224
That is only gonna get enhanced by AI,

91
00:03:42,004 --> 00:03:44,004
and other tools. And then you've got a

92
00:03:44,004 --> 00:03:44,504
Fed

93
00:03:45,099 --> 00:03:45,599
that

94
00:03:46,219 --> 00:03:49,180
has accelerated approval programs, things like that. So,

95
00:03:49,180 --> 00:03:50,879
you know, really, the track is

96
00:03:51,180 --> 00:03:53,599
is slick and and drugs are gonna come.

97
00:03:54,139 --> 00:03:56,060
And then you've got, you know, drug pricing,

98
00:03:56,060 --> 00:03:57,759
which never seems to end.

99
00:03:58,139 --> 00:03:59,199
And then the IRA.

100
00:03:59,844 --> 00:04:01,305
You know, I I think the IRA,

101
00:04:01,765 --> 00:04:04,025
what's been done for the benefit

102
00:04:04,885 --> 00:04:07,865
is just tremendous for patients, for providers.

103
00:04:08,325 --> 00:04:11,125
We're finally gonna close the donut hole. We're

104
00:04:11,125 --> 00:04:14,269
gonna cap, you know, patients' cost at $2,000

105
00:04:15,050 --> 00:04:17,790
on drug. I mean, that's literally a 150

106
00:04:18,089 --> 00:04:19,230
plus a month,

107
00:04:19,610 --> 00:04:21,290
and you get all the drugs you want.

108
00:04:21,290 --> 00:04:23,629
And and so, and then we fundamentally

109
00:04:24,009 --> 00:04:25,229
changed the math

110
00:04:25,644 --> 00:04:28,685
in the equation. So who's responsible for what?

111
00:04:28,685 --> 00:04:30,284
So you're gonna see, you know, you're gonna

112
00:04:30,284 --> 00:04:32,204
see some growing pains as we get through

113
00:04:32,204 --> 00:04:34,685
that. And then, of course, we have drug

114
00:04:34,685 --> 00:04:36,625
negotiation, which will kick in,

115
00:04:37,564 --> 00:04:39,485
a little while, and anyone that tells you

116
00:04:39,485 --> 00:04:41,009
they they understand the

117
00:04:41,410 --> 00:04:41,910
of

118
00:04:42,290 --> 00:04:44,310
that, we're only just speculating

119
00:04:44,610 --> 00:04:45,509
at this point.

120
00:04:46,129 --> 00:04:47,910
And and you've got PBM reform.

121
00:04:48,610 --> 00:04:51,110
And and PBM reform is gaining attention.

122
00:04:51,650 --> 00:04:53,810
You see all the activity. You see a

123
00:04:53,810 --> 00:04:56,074
lot of the rhetoric coming out of the

124
00:04:56,074 --> 00:04:56,735
the FTC,

125
00:04:57,915 --> 00:04:59,855
and who knows where that lands.

126
00:05:00,795 --> 00:05:02,235
But at the end of the day, we

127
00:05:02,235 --> 00:05:04,735
we can't let any of this distract us.

128
00:05:05,514 --> 00:05:06,254
We have

129
00:05:06,634 --> 00:05:09,490
we have we have got to get the

130
00:05:09,490 --> 00:05:11,889
value of drug. And so, you know, at

131
00:05:11,889 --> 00:05:13,189
at my plan,

132
00:05:13,490 --> 00:05:16,230
we're really trying to engage all the stakeholders,

133
00:05:16,449 --> 00:05:17,189
our members,

134
00:05:17,569 --> 00:05:18,550
our providers,

135
00:05:19,490 --> 00:05:20,629
pharmaceutical manufacturers,

136
00:05:21,415 --> 00:05:22,394
retail pharmacists,

137
00:05:22,694 --> 00:05:24,854
anybody who touches the patient because I think

138
00:05:24,854 --> 00:05:26,074
that's the way we're

139
00:05:26,454 --> 00:05:27,995
gonna get to better care,

140
00:05:28,535 --> 00:05:30,475
better member education, etcetera.

141
00:05:31,975 --> 00:05:34,055
Absolutely. It's such a great message that there

142
00:05:34,055 --> 00:05:37,210
is a lot of swirling conversations and messages

143
00:05:37,270 --> 00:05:38,870
going on right now all over the country

144
00:05:38,870 --> 00:05:40,490
and certainly in Washington around

145
00:05:40,870 --> 00:05:43,430
drug costs. You mentioned the PBM conversations that

146
00:05:43,430 --> 00:05:44,949
are going on in the headlines that we

147
00:05:44,949 --> 00:05:48,009
see almost daily, Cronus, around this this topic,

148
00:05:48,245 --> 00:05:49,845
but a but a great message that you're

149
00:05:49,845 --> 00:05:52,324
focused on on drug costs and access for

150
00:05:52,324 --> 00:05:54,504
your members at UPMC Health Plan.

151
00:05:55,045 --> 00:05:57,045
And fascinating to hear you talk about how

152
00:05:57,045 --> 00:05:59,205
you think we're at the apex of of

153
00:05:59,205 --> 00:05:59,705
pharmacy,

154
00:06:00,959 --> 00:06:03,439
interest right now across across the media and

155
00:06:03,439 --> 00:06:04,500
the general public.

156
00:06:04,959 --> 00:06:07,600
But you mentioned something earlier in terms of

157
00:06:07,600 --> 00:06:08,980
drug costs and

158
00:06:09,360 --> 00:06:12,000
one drug class that we've seen mentioned over

159
00:06:12,000 --> 00:06:13,779
and over again this year,

160
00:06:14,480 --> 00:06:16,339
by health plans like you,

161
00:06:17,514 --> 00:06:18,814
by self insured employers,

162
00:06:19,194 --> 00:06:21,754
by public health plans like state governments all

163
00:06:21,754 --> 00:06:23,694
over the country. They're talking about GLP-1s.

164
00:06:24,395 --> 00:06:27,035
So and the cost, some some payers have

165
00:06:27,035 --> 00:06:29,275
even completely dropped coverage of these drugs because

166
00:06:29,275 --> 00:06:30,814
of because of the high costs.

167
00:06:31,194 --> 00:06:33,209
So how are you dealing with this? Some

168
00:06:33,209 --> 00:06:35,470
have some have called this GLP one insanity,

169
00:06:36,329 --> 00:06:38,970
dominating the pharmacy space. Where do you view

170
00:06:38,970 --> 00:06:41,449
this from from the perspective of UPMC Health

171
00:06:41,449 --> 00:06:41,949
Plan?

172
00:06:42,810 --> 00:06:44,649
Well, you know, let let me take a

173
00:06:44,649 --> 00:06:46,810
step back first because, you know, when we

174
00:06:46,810 --> 00:06:49,435
talk about Apex and and what that means,

175
00:06:49,895 --> 00:06:51,835
I I judge it very simply.

176
00:06:52,295 --> 00:06:55,095
What what drug names does my CFO know?

177
00:06:55,095 --> 00:06:55,595
Right?

178
00:06:55,895 --> 00:06:59,254
Everybody knows the GLPs. Right? The the my

179
00:06:59,254 --> 00:07:02,169
neighbors know about GLPs, and it really and

180
00:07:02,169 --> 00:07:04,430
I I think January of 23,

181
00:07:05,129 --> 00:07:07,069
the combination of the pandemic,

182
00:07:08,410 --> 00:07:10,810
and, you know, really the world getting back

183
00:07:10,810 --> 00:07:11,310
together,

184
00:07:11,689 --> 00:07:14,810
there was just this really social media craze

185
00:07:14,810 --> 00:07:17,495
about what these drugs could do. We've had

186
00:07:17,495 --> 00:07:20,235
GLPs for diabetes for a long time.

187
00:07:21,014 --> 00:07:23,514
And but there was just a whole different,

188
00:07:25,014 --> 00:07:26,235
accelerant there.

189
00:07:26,935 --> 00:07:28,615
But I I think, you know, the way

190
00:07:28,615 --> 00:07:30,314
I look at it is we have to

191
00:07:31,259 --> 00:07:33,980
really separate the 2 types of GLPs. There

192
00:07:33,980 --> 00:07:35,680
there are GLPs for diabetes,

193
00:07:36,379 --> 00:07:39,259
and those are Ozempic and and Monjaro and

194
00:07:39,259 --> 00:07:41,740
Trulicity, and then there are the GLPs for

195
00:07:41,740 --> 00:07:42,480
weight loss.

196
00:07:42,875 --> 00:07:45,115
And, you know, the the and we tend,

197
00:07:45,115 --> 00:07:47,675
as a population, we just blend them all

198
00:07:47,675 --> 00:07:48,175
together.

199
00:07:49,194 --> 00:07:49,694
And,

200
00:07:50,235 --> 00:07:52,254
and and it's because of the shortages.

201
00:07:52,875 --> 00:07:54,634
You know, people were trying to use one

202
00:07:54,634 --> 00:07:56,639
instead of the other, and and, you know,

203
00:07:56,639 --> 00:07:59,439
we we've got shortages that are impacting diabetics.

204
00:07:59,439 --> 00:08:01,439
And sometimes the shortages are for the weight

205
00:08:01,439 --> 00:08:03,839
loss drugs that impact other you know, interrupt

206
00:08:03,839 --> 00:08:04,819
people's treatment.

207
00:08:05,279 --> 00:08:06,879
But at the end of the day, the

208
00:08:06,879 --> 00:08:08,100
demand is incredible.

209
00:08:08,639 --> 00:08:09,860
We've had shortages,

210
00:08:11,095 --> 00:08:11,595
and

211
00:08:12,134 --> 00:08:13,995
these shortages are being mitigated.

212
00:08:14,535 --> 00:08:17,415
It makes us really nervous to see what

213
00:08:17,415 --> 00:08:20,535
is gonna happen to this category. We've had

214
00:08:20,535 --> 00:08:21,035
sequential

215
00:08:21,894 --> 00:08:23,834
quarter over quarter growth

216
00:08:24,134 --> 00:08:25,194
in double digits,

217
00:08:25,860 --> 00:08:28,279
And I can't remember a drug category

218
00:08:29,060 --> 00:08:32,279
that's had that kind of action to it.

219
00:08:32,980 --> 00:08:35,220
And, you know, I and think about it.

220
00:08:35,220 --> 00:08:36,839
For weight loss drugs,

221
00:08:37,539 --> 00:08:40,084
most people don't cover them. Right? So you

222
00:08:40,245 --> 00:08:42,024
Medicare, it's a it's an exclusion,

223
00:08:42,485 --> 00:08:43,784
and I guarantee you

224
00:08:44,164 --> 00:08:45,704
it won't be that way for long.

225
00:08:46,725 --> 00:08:48,424
We will start to see,

226
00:08:48,884 --> 00:08:49,625
the pressure

227
00:08:50,164 --> 00:08:52,964
from all sides to to cover these drugs

228
00:08:52,964 --> 00:08:53,625
in Medicare.

229
00:08:54,200 --> 00:08:56,919
And in commercial, you know, we it's a

230
00:08:56,919 --> 00:08:59,960
buy up generally. And commercial plans like ours

231
00:08:59,960 --> 00:09:02,200
that have large fully insured books, we're on

232
00:09:02,200 --> 00:09:03,179
the same pressure.

233
00:09:03,639 --> 00:09:05,240
You you can't have it both ways. You

234
00:09:05,240 --> 00:09:06,299
can't blame obesity,

235
00:09:07,894 --> 00:09:09,674
on everything that ails us downstream

236
00:09:10,375 --> 00:09:12,934
and then, you know, not cover the drugs

237
00:09:12,934 --> 00:09:14,855
because these are effective drugs. It was different

238
00:09:14,855 --> 00:09:17,334
when we didn't have effective drugs. These drugs

239
00:09:17,334 --> 00:09:18,314
were 15%,

240
00:09:18,694 --> 00:09:20,154
you know, body weight potential.

241
00:09:21,230 --> 00:09:23,809
So but it's such a massive population.

242
00:09:24,350 --> 00:09:27,230
And the data, the early data is just

243
00:09:27,230 --> 00:09:28,529
really early discontinuing

244
00:09:28,909 --> 00:09:31,409
rates. Right? So what did we really accomplish?

245
00:09:31,470 --> 00:09:32,610
And the other thing,

246
00:09:33,125 --> 00:09:35,044
the elephant in the room is people gain

247
00:09:35,044 --> 00:09:37,044
the weight back. Not everybody. You know, if

248
00:09:37,044 --> 00:09:39,204
you if you adopt the right lifestyle, who

249
00:09:39,204 --> 00:09:41,044
knows? But that's where a lot of the

250
00:09:41,044 --> 00:09:43,704
manufacturers are going next. How do we find

251
00:09:44,084 --> 00:09:46,159
drugs that where you don't gain the weight

252
00:09:46,159 --> 00:09:49,519
back as easily when you return return normal

253
00:09:49,519 --> 00:09:51,839
life? So and, additionally, you know, you we

254
00:09:51,839 --> 00:09:54,639
had all these compounding shops that are popping

255
00:09:54,639 --> 00:09:56,100
up all over the place,

256
00:09:56,799 --> 00:09:58,579
and and then we've got the manufacturers

257
00:09:59,039 --> 00:10:01,059
themselves going direct to consumer.

258
00:10:01,815 --> 00:10:03,915
You don't see a lot of that certainly.

259
00:10:04,535 --> 00:10:07,274
So here's where I just have a real

260
00:10:07,335 --> 00:10:07,835
challenge,

261
00:10:09,175 --> 00:10:10,855
and I get it, but these are really

262
00:10:10,855 --> 00:10:12,075
good diabetes drugs.

263
00:10:12,455 --> 00:10:14,455
We went from a period of time for

264
00:10:14,455 --> 00:10:16,695
type 2 diabetes that we didn't have great

265
00:10:16,695 --> 00:10:19,389
drugs. These are good drugs. You know, they're

266
00:10:19,389 --> 00:10:22,669
cardio protective. They you lose weight, which helps

267
00:10:22,669 --> 00:10:23,570
in type 2.

268
00:10:23,950 --> 00:10:25,730
You have a one c reduction.

269
00:10:26,669 --> 00:10:27,809
And yet

270
00:10:28,269 --> 00:10:29,330
the explosion

271
00:10:29,870 --> 00:10:32,669
of cost and demand has caused a lot

272
00:10:32,669 --> 00:10:34,615
of our stakeholders to say,

273
00:10:35,075 --> 00:10:37,955
you know, manage these drugs. Put more prior

274
00:10:37,955 --> 00:10:40,455
auth on. Put, you know, more management.

275
00:10:40,995 --> 00:10:43,894
We can't afford the costs anymore.

276
00:10:44,514 --> 00:10:46,035
And I I you know, again, I've been

277
00:10:46,035 --> 00:10:48,600
I've been at UPMC for for 18 plus,

278
00:10:48,600 --> 00:10:49,419
and I've been,

279
00:10:49,879 --> 00:10:51,959
in the industry in managed care for a

280
00:10:51,959 --> 00:10:53,980
long time. I I don't ever remember

281
00:10:54,519 --> 00:10:57,259
that we put barriers on diabetes drugs,

282
00:10:58,039 --> 00:11:01,000
and that is really something to think about.

283
00:11:01,000 --> 00:11:02,919
What what are we gonna do tomorrow when

284
00:11:02,919 --> 00:11:03,659
the innovation

285
00:11:04,654 --> 00:11:06,355
is gonna be even greater?

286
00:11:06,815 --> 00:11:08,674
I I I think that is

287
00:11:09,695 --> 00:11:10,514
our challenge.

288
00:11:11,535 --> 00:11:13,075
But look. You know, I I also,

289
00:11:14,095 --> 00:11:15,475
I came from the

290
00:11:16,095 --> 00:11:18,174
the you know, a world where, you know,

291
00:11:18,174 --> 00:11:20,539
there's been lots of these kinds of blips,

292
00:11:21,000 --> 00:11:23,559
and we'll manage through them. But, anyway, I

293
00:11:23,559 --> 00:11:25,320
think that's what we're trying to hold on

294
00:11:25,320 --> 00:11:25,820
to.

295
00:11:26,919 --> 00:11:28,919
Wow. I I mean, just so interesting to

296
00:11:28,919 --> 00:11:30,360
hear you talk about this. So many different

297
00:11:30,360 --> 00:11:32,360
angles and nuances that we could attack this

298
00:11:32,360 --> 00:11:34,665
conversation from, but so interesting to hear that

299
00:11:34,665 --> 00:11:36,904
this is the the most explosive drug growth

300
00:11:36,904 --> 00:11:38,684
you've seen in your career,

301
00:11:38,985 --> 00:11:41,225
Cronus. And and, you know, to your point

302
00:11:41,225 --> 00:11:42,985
is well heard in terms of people often

303
00:11:42,985 --> 00:11:44,504
do gain the weight back on these drugs.

304
00:11:44,504 --> 00:11:46,285
And we saw the largest study

305
00:11:46,639 --> 00:11:48,799
to date on on that topic from Blue

306
00:11:48,799 --> 00:11:50,639
Cross Blue Shield come out earlier this year,

307
00:11:50,639 --> 00:11:53,360
finding almost 60% of the people prescribed these

308
00:11:53,360 --> 00:11:53,860
medications

309
00:11:54,320 --> 00:11:56,820
don't actually reach a meaningful health benefit. So

310
00:11:57,200 --> 00:11:59,039
to your point, it is fascinating to see

311
00:11:59,039 --> 00:12:00,960
the research and and the data points that

312
00:12:00,960 --> 00:12:02,115
are coming out about this.

313
00:12:02,674 --> 00:12:04,115
You you had said earlier too that it's

314
00:12:04,115 --> 00:12:06,514
not it's not necessarily just GLP ones, you

315
00:12:06,514 --> 00:12:08,914
know, driving up these costs. It's specialty drugs

316
00:12:08,914 --> 00:12:11,414
in general. And we've also been hearing employers

317
00:12:11,554 --> 00:12:13,794
self insured this year talk about the the

318
00:12:13,794 --> 00:12:16,534
rising cost of cardiac and cancer drugs.

319
00:12:16,910 --> 00:12:19,090
So I think the broader question here, Cronos,

320
00:12:19,149 --> 00:12:20,830
is what's keeping you up at night from

321
00:12:20,830 --> 00:12:24,210
a broader drug access and affordability perspective

322
00:12:24,750 --> 00:12:25,730
for your members?

323
00:12:27,309 --> 00:12:29,549
Well, I think the biggest change that I've

324
00:12:29,549 --> 00:12:31,784
seen over my career is we just were

325
00:12:31,784 --> 00:12:33,725
running out of levers in pharmacy

326
00:12:34,105 --> 00:12:36,584
to manage cost. If you whether you like

327
00:12:36,584 --> 00:12:39,725
them or not, our traditional levers were really,

328
00:12:40,105 --> 00:12:41,245
you know, pay

329
00:12:41,625 --> 00:12:42,684
squeeze pharmacies

330
00:12:43,065 --> 00:12:43,565
more,

331
00:12:44,279 --> 00:12:46,699
drive try to squeeze pharma

332
00:12:47,480 --> 00:12:49,559
more, in the in the sense of more

333
00:12:49,559 --> 00:12:50,059
rebating.

334
00:12:50,440 --> 00:12:52,620
It was really a volume play.

335
00:12:53,079 --> 00:12:55,240
And if if you if you kinda look

336
00:12:55,240 --> 00:12:58,065
at it and and utilization management, prior auth.

337
00:12:58,065 --> 00:13:00,144
Right? And if you look at those levers

338
00:13:00,384 --> 00:13:02,404
and and so we would live off of

339
00:13:03,105 --> 00:13:04,485
really just driving,

340
00:13:05,184 --> 00:13:06,964
the supply chain down

341
00:13:07,424 --> 00:13:08,245
and squeezing

342
00:13:08,625 --> 00:13:10,945
cost out of it. And and now you

343
00:13:10,945 --> 00:13:11,764
look at it.

344
00:13:12,309 --> 00:13:13,129
Prior authorizations

345
00:13:13,509 --> 00:13:15,430
is is out of favor. You know, there's

346
00:13:15,430 --> 00:13:17,210
lots of enemies out there.

347
00:13:17,590 --> 00:13:19,029
I don't know that I agree with it.

348
00:13:19,029 --> 00:13:20,649
I think it's it's right,

349
00:13:21,190 --> 00:13:23,830
but there is there is it's become table

350
00:13:23,830 --> 00:13:25,290
stakes. It's not really

351
00:13:25,654 --> 00:13:27,495
a lever the way we used to think

352
00:13:27,495 --> 00:13:28,235
about it.

353
00:13:28,695 --> 00:13:32,215
Network pharmacies have become really noisy, and and

354
00:13:32,215 --> 00:13:33,115
rightly so.

355
00:13:33,654 --> 00:13:36,154
And that's what's driving all the PBM consternation.

356
00:13:37,415 --> 00:13:40,159
So anyone who's thinks they're gonna live on

357
00:13:40,159 --> 00:13:41,779
reduced pharmacy reimbursement,

358
00:13:43,360 --> 00:13:44,579
it's not gonna happen.

359
00:13:44,959 --> 00:13:46,820
I see it as like hospitals.

360
00:13:47,200 --> 00:13:48,100
We give hospitals

361
00:13:48,720 --> 00:13:52,079
cost of living increases. That's never happened in

362
00:13:52,079 --> 00:13:52,579
pharmacy.

363
00:13:52,959 --> 00:13:53,715
But I think

364
00:13:54,115 --> 00:13:56,695
network pharmacies have really reached the bottom.

365
00:13:57,235 --> 00:13:59,315
You know, in one sense, PBMs did their

366
00:13:59,315 --> 00:14:01,254
job. We went out and charged them

367
00:14:01,795 --> 00:14:04,035
to reduce costs, but, you know, we've kinda

368
00:14:04,035 --> 00:14:06,055
tilted too far to the other side.

369
00:14:06,514 --> 00:14:08,434
So I I think that's a lever that's

370
00:14:08,434 --> 00:14:10,559
not gonna happen. Rebate uncertainty

371
00:14:11,100 --> 00:14:13,580
is is really what's out there. Right? So

372
00:14:13,580 --> 00:14:13,980
there's been

373
00:14:14,700 --> 00:14:17,120
you know, we've we've rode that wave.

374
00:14:17,980 --> 00:14:19,440
Now with drug negotiation

375
00:14:19,899 --> 00:14:21,360
on the Medicare side,

376
00:14:21,740 --> 00:14:24,000
what will pharma do on the

377
00:14:24,464 --> 00:14:26,625
on the rebate side? What will they do

378
00:14:26,625 --> 00:14:29,365
crossover into commercial? Will there be unintended

379
00:14:29,824 --> 00:14:31,044
consequences there?

380
00:14:31,424 --> 00:14:32,725
And, you know, biosimilars,

381
00:14:34,384 --> 00:14:36,164
sure, we've saved some money,

382
00:14:36,779 --> 00:14:39,440
but, you know, not like I think everyone

383
00:14:39,579 --> 00:14:41,360
thought. It's it's it's opaque.

384
00:14:41,820 --> 00:14:44,399
It's hard to explain. The brand name companies

385
00:14:44,459 --> 00:14:45,199
are are

386
00:14:45,500 --> 00:14:46,559
all involved.

387
00:14:47,179 --> 00:14:48,940
And and so I I think, you know,

388
00:14:48,940 --> 00:14:50,959
you you you you have these levers.

389
00:14:51,534 --> 00:14:53,634
You have the demand for,

390
00:14:54,575 --> 00:14:56,034
these innovative therapies,

391
00:14:56,414 --> 00:14:56,914
like,

392
00:14:57,534 --> 00:15:00,254
the gene therapies and rare therapies. They just

393
00:15:00,254 --> 00:15:03,774
come to market faster and faster, aided by

394
00:15:03,774 --> 00:15:04,434
the FDA,

395
00:15:04,815 --> 00:15:06,034
aided by technology,

396
00:15:07,500 --> 00:15:08,800
and then you layer on

397
00:15:09,259 --> 00:15:11,120
inequities and health disparities.

398
00:15:11,660 --> 00:15:14,059
Even when we give drugs away, people don't

399
00:15:14,059 --> 00:15:16,860
understand them. They don't take them, and that's

400
00:15:16,860 --> 00:15:18,000
not gonna be,

401
00:15:18,540 --> 00:15:19,034
something.

402
00:15:19,595 --> 00:15:21,034
So at the end of the day, you

403
00:15:21,034 --> 00:15:23,674
know, we have been through this before. So

404
00:15:23,674 --> 00:15:25,294
in the in the early 2000,

405
00:15:26,554 --> 00:15:27,615
5 drug categories

406
00:15:28,235 --> 00:15:28,735
drove

407
00:15:29,115 --> 00:15:30,095
a significant

408
00:15:30,475 --> 00:15:30,975
cost.

409
00:15:31,649 --> 00:15:32,389
Those categories

410
00:15:32,690 --> 00:15:33,669
were statins,

411
00:15:34,449 --> 00:15:34,949
PPIs,

412
00:15:35,490 --> 00:15:36,949
non sedating antihistamines,

413
00:15:37,970 --> 00:15:38,470
SSRIs,

414
00:15:40,610 --> 00:15:41,110
and,

415
00:15:42,209 --> 00:15:44,529
ACEs and ARBs. And if you look at

416
00:15:44,529 --> 00:15:47,704
it, those 5 categories, they're still the standard

417
00:15:47,704 --> 00:15:50,664
of care. They're all just generics and pretty

418
00:15:50,664 --> 00:15:53,384
much give them away. But managed care had

419
00:15:53,384 --> 00:15:54,924
to work their way through it.

420
00:15:55,704 --> 00:15:58,039
I find ourselves in a similar spot. We're

421
00:15:58,039 --> 00:15:59,879
gonna have to work our way through it.

422
00:15:59,879 --> 00:16:01,960
The pressure will be there. The demand will

423
00:16:01,960 --> 00:16:02,620
be there.

424
00:16:03,000 --> 00:16:05,159
But I do get I do get,

425
00:16:05,799 --> 00:16:07,580
concerned that the lever's

426
00:16:07,960 --> 00:16:10,519
not sure where the affordability is gonna come

427
00:16:10,519 --> 00:16:11,019
from.

428
00:16:12,024 --> 00:16:15,404
Absolutely. So so health plans, your employer customers,

429
00:16:15,544 --> 00:16:17,625
you're running out of the levers to manage

430
00:16:17,625 --> 00:16:19,865
these pharmacy costs. I think the natural question

431
00:16:19,865 --> 00:16:21,884
to that, Cronos, is if you you personally

432
00:16:21,945 --> 00:16:24,024
could wave a magic wand, what are the

433
00:16:24,024 --> 00:16:25,804
some of the things that you would change

434
00:16:26,100 --> 00:16:27,000
policy wise

435
00:16:27,379 --> 00:16:30,360
in in the private market to ensure preservation

436
00:16:30,659 --> 00:16:32,120
of the pharmacy benefit?

437
00:16:33,139 --> 00:16:35,220
Well, I mean, I I I'm gonna make

438
00:16:35,220 --> 00:16:36,039
this simple,

439
00:16:36,579 --> 00:16:38,279
and it's not. But,

440
00:16:39,444 --> 00:16:41,924
you know, we need value in pharmacy. There

441
00:16:42,004 --> 00:16:44,424
there's very little value based

442
00:16:45,444 --> 00:16:45,944
construct

443
00:16:46,245 --> 00:16:48,584
in pharmacy. And what I mean by that,

444
00:16:49,444 --> 00:16:51,629
we still pay you know, I I I

445
00:16:51,629 --> 00:16:53,170
worked at a retail pharmacy,

446
00:16:53,549 --> 00:16:56,029
you know, many, many, many years ago. It's

447
00:16:56,029 --> 00:16:57,950
it's not a whole lot different. You have

448
00:16:57,950 --> 00:16:59,330
automation. You have technology,

449
00:17:00,190 --> 00:17:02,670
but you're still making margin on on drug.

450
00:17:02,670 --> 00:17:05,089
You're still make you're all of the clinical

451
00:17:05,230 --> 00:17:05,730
services

452
00:17:06,255 --> 00:17:07,634
we get out of pharmacies

453
00:17:08,335 --> 00:17:10,035
are funded by drug margin.

454
00:17:10,494 --> 00:17:12,734
It it doesn't make any sense. Right? It's

455
00:17:12,734 --> 00:17:13,055
certainly

456
00:17:13,535 --> 00:17:16,015
you know, it flies it's the direct opposite

457
00:17:16,015 --> 00:17:17,695
of what we do on the medical side

458
00:17:17,695 --> 00:17:19,259
of the house where we, you know, we

459
00:17:19,259 --> 00:17:21,840
have the ACO model. We have more physicians

460
00:17:21,900 --> 00:17:22,640
at risk.

461
00:17:23,019 --> 00:17:25,259
You're you have alignment. We don't have any

462
00:17:25,259 --> 00:17:26,720
of that pharmacy today.

463
00:17:27,019 --> 00:17:29,580
And I think, that's just one aspect of

464
00:17:29,580 --> 00:17:32,160
it. When you think about these rare therapies

465
00:17:32,220 --> 00:17:33,519
that are coming to market,

466
00:17:34,095 --> 00:17:36,494
The structure we've had over the last 20

467
00:17:36,494 --> 00:17:37,554
years has been,

468
00:17:38,095 --> 00:17:39,855
let me get my drug on formulary, and

469
00:17:39,855 --> 00:17:42,255
I'll pay you a discount. How about let's

470
00:17:42,255 --> 00:17:43,634
see if your drug works,

471
00:17:44,095 --> 00:17:45,869
and then we'll see what the price is

472
00:17:45,950 --> 00:17:49,390
gonna be. So outcomes based contracts, value based

473
00:17:49,390 --> 00:17:52,130
contracts, we need those in pharmacy as well.

474
00:17:52,910 --> 00:17:55,710
Those are coming, but they're I think we're

475
00:17:55,710 --> 00:17:58,450
kicking and screaming and dragging everybody with us.

476
00:17:58,829 --> 00:18:01,150
And then physician risk models as well. We

477
00:18:01,150 --> 00:18:03,525
we we talk all the time with

478
00:18:03,985 --> 00:18:06,384
docs are frustrated because the drugs are so

479
00:18:06,384 --> 00:18:08,485
expensive. They don't always have the tools.

480
00:18:08,865 --> 00:18:10,144
But at the end of the day, they

481
00:18:10,144 --> 00:18:12,785
control the scripts, so we have to have

482
00:18:12,785 --> 00:18:14,805
them involved. So in my opinion,

483
00:18:15,599 --> 00:18:16,819
in order to,

484
00:18:17,759 --> 00:18:21,759
really get everybody aligned, including the PBMs who,

485
00:18:21,759 --> 00:18:24,420
you know, started out as the greatest concept,

486
00:18:24,559 --> 00:18:27,299
you know, you can real time alert people

487
00:18:28,115 --> 00:18:30,275
before the drugs go over the wall. All

488
00:18:30,275 --> 00:18:32,835
that great technology, but they've, you know, they've

489
00:18:32,835 --> 00:18:33,735
been able to

490
00:18:34,674 --> 00:18:37,875
vertically integrate and and really find themselves in

491
00:18:37,875 --> 00:18:40,455
lots of different businesses with lots of different

492
00:18:40,515 --> 00:18:41,015
conflicts.

493
00:18:41,599 --> 00:18:42,740
We need to get value.

494
00:18:43,119 --> 00:18:44,259
We need to get everybody,

495
00:18:45,119 --> 00:18:45,859
on board.

496
00:18:46,320 --> 00:18:48,320
And I think it's gonna be uncomfortable for

497
00:18:48,320 --> 00:18:50,320
a lot. And because we didn't get here

498
00:18:50,320 --> 00:18:50,820
overnight,

499
00:18:51,200 --> 00:18:53,940
if you want change, everyone's gonna give,

500
00:18:54,434 --> 00:18:56,355
and it's gonna be a you're gonna have

501
00:18:56,355 --> 00:18:59,075
to give to the uncomfortable point. But we

502
00:18:59,075 --> 00:19:00,215
gotta start somewhere.

503
00:19:01,555 --> 00:19:03,634
Kronos, what what do you make of, some

504
00:19:03,634 --> 00:19:04,775
of the large PBMs,

505
00:19:05,315 --> 00:19:05,815
Optum,

506
00:19:06,115 --> 00:19:06,615
Caremark,

507
00:19:07,075 --> 00:19:09,269
I believe Express Scripts has as well, launching

508
00:19:09,970 --> 00:19:11,109
with what they call,

509
00:19:11,730 --> 00:19:13,829
more more cost plus transparent

510
00:19:14,529 --> 00:19:15,029
models

511
00:19:15,650 --> 00:19:18,869
amid the rise of Mark Cuban's pharmacy company.

512
00:19:19,730 --> 00:19:21,289
Any any thoughts there in terms of, you

513
00:19:21,289 --> 00:19:23,329
know, you mentioned the value based outcomes based

514
00:19:23,329 --> 00:19:23,829
contracts.

515
00:19:24,255 --> 00:19:26,255
Are these new models examples of what you're

516
00:19:26,255 --> 00:19:27,954
talking about, or is this more

517
00:19:28,494 --> 00:19:30,974
public relations fluff? Where do you kind of

518
00:19:30,974 --> 00:19:32,115
fall on that?

519
00:19:33,295 --> 00:19:33,795
Well,

520
00:19:34,414 --> 00:19:38,095
TBD. Right? I mean, I've been advocating for

521
00:19:38,095 --> 00:19:39,875
a cost plus model,

522
00:19:40,950 --> 00:19:43,049
from the PBMs for a lot of years.

523
00:19:43,190 --> 00:19:43,589
And,

524
00:19:44,069 --> 00:19:46,390
we currently use Express Scripts, and we we

525
00:19:46,390 --> 00:19:47,609
talk about it a lot.

526
00:19:48,230 --> 00:19:49,130
But I think,

527
00:19:50,069 --> 00:19:52,970
cost plus needs to be associated with transparency,

528
00:19:53,829 --> 00:19:56,125
and I think what's happening is you're you're

529
00:19:56,125 --> 00:19:56,625
getting,

530
00:19:57,325 --> 00:19:59,325
you're getting the little guys to force the

531
00:19:59,325 --> 00:20:01,984
big guys to to get get in line.

532
00:20:02,765 --> 00:20:03,265
But

533
00:20:03,565 --> 00:20:06,525
I think I think the fundamental challenge we

534
00:20:06,525 --> 00:20:07,025
have

535
00:20:07,484 --> 00:20:08,305
is that

536
00:20:08,700 --> 00:20:09,200
government

537
00:20:09,740 --> 00:20:12,619
business is really tough, Medicare especially. I mean,

538
00:20:12,619 --> 00:20:14,720
think about the rocket science of

539
00:20:15,019 --> 00:20:16,079
having to calculate

540
00:20:16,460 --> 00:20:17,519
all those dollars

541
00:20:17,899 --> 00:20:20,539
in real time, and and, you know, a

542
00:20:20,539 --> 00:20:23,339
lot of smaller PBMs don't wanna invest in

543
00:20:23,339 --> 00:20:23,839
Medicare.

544
00:20:24,644 --> 00:20:26,424
So plans like ours

545
00:20:27,285 --> 00:20:28,105
that have,

546
00:20:28,484 --> 00:20:30,724
multiple lines of business, you know, there's a

547
00:20:30,724 --> 00:20:33,125
there's a limited field out there. But, you

548
00:20:33,125 --> 00:20:35,045
know, it's a start. It it's that's what

549
00:20:35,045 --> 00:20:37,625
competition does, so so that's great.

550
00:20:38,005 --> 00:20:39,045
You know, I I think,

551
00:20:39,859 --> 00:20:42,200
personally, though, I'll I'll I'll say this.

552
00:20:42,580 --> 00:20:45,059
The more we fragment the care, the more

553
00:20:45,059 --> 00:20:47,640
cost plus pharmacies that show up.

554
00:20:48,340 --> 00:20:51,220
It's gonna destroy the PBM model. I'm not

555
00:20:51,220 --> 00:20:54,099
shy about saying it, and I'll defend it

556
00:20:54,099 --> 00:20:55,080
all day long.

557
00:20:55,460 --> 00:20:58,714
The PBM model was built for all the

558
00:20:58,714 --> 00:21:00,335
claims to be in the pool.

559
00:21:00,714 --> 00:21:02,795
When the claims are in the pool, you

560
00:21:02,795 --> 00:21:05,355
can run all those safety checks. When the

561
00:21:05,355 --> 00:21:07,134
claims aren't in the pool anymore,

562
00:21:07,930 --> 00:21:10,029
Think about what a medication reconciliation.

563
00:21:10,570 --> 00:21:11,789
So we've got CMS

564
00:21:12,650 --> 00:21:15,049
paying us to do med rec in our

565
00:21:15,049 --> 00:21:15,950
stars programs.

566
00:21:16,330 --> 00:21:18,410
And yet, you know, 3 of the 12

567
00:21:18,410 --> 00:21:19,470
claims are missing.

568
00:21:20,265 --> 00:21:22,265
What? How does that help? So I am

569
00:21:22,265 --> 00:21:24,904
very sympathetic that people have to find their

570
00:21:24,904 --> 00:21:25,404
ways

571
00:21:25,705 --> 00:21:26,445
to affordability.

572
00:21:27,305 --> 00:21:30,025
But if we don't data share and care

573
00:21:30,025 --> 00:21:32,505
coordinate to make sure all of our current

574
00:21:32,505 --> 00:21:33,005
safeguards

575
00:21:33,465 --> 00:21:33,965
operate,

576
00:21:34,759 --> 00:21:36,460
I'm not sure what we've accomplished.

577
00:21:38,360 --> 00:21:40,299
It's fascinating and big predictions

578
00:21:40,600 --> 00:21:43,880
from you, Ronis. Yeah. Any anything else we're

579
00:21:43,880 --> 00:21:46,680
missing? Any any final thoughts you wanna provide

580
00:21:46,680 --> 00:21:48,424
while you have the ears of a lot

581
00:21:48,424 --> 00:21:51,085
of health plan peers all over the country?

582
00:21:52,184 --> 00:21:54,285
You know, I think we can't get distracted,

583
00:21:54,585 --> 00:21:56,365
and we have to weather the storm.

584
00:21:56,744 --> 00:21:58,924
It is like I said, it's pretty intense

585
00:21:59,065 --> 00:22:00,365
environment right now,

586
00:22:00,820 --> 00:22:03,080
and it's also, you know, being,

587
00:22:04,259 --> 00:22:07,140
driven by it's complex on the medical side

588
00:22:07,140 --> 00:22:09,220
as well. And so for the first time

589
00:22:09,220 --> 00:22:11,059
in a long time, you know, drug was

590
00:22:11,059 --> 00:22:12,440
kind of the sidecar,

591
00:22:13,804 --> 00:22:16,125
but, you know, you've seen all the Medicare

592
00:22:16,125 --> 00:22:16,625
Advantage,

593
00:22:17,325 --> 00:22:18,224
all the utilization.

594
00:22:19,085 --> 00:22:21,085
You've seen a lot of the challenges with

595
00:22:21,085 --> 00:22:21,585
Medicaid.

596
00:22:22,204 --> 00:22:23,664
And then drug is just

597
00:22:24,285 --> 00:22:26,525
you could in the past, maybe have bailed

598
00:22:26,525 --> 00:22:28,720
some of that out, and now it's just

599
00:22:28,799 --> 00:22:31,519
it's really challenging in drug as well. And

600
00:22:31,519 --> 00:22:32,960
I think it just puts a lot of

601
00:22:32,960 --> 00:22:34,419
pressure on, but we've gotta

602
00:22:34,880 --> 00:22:36,980
stay committed to the membership.

603
00:22:37,919 --> 00:22:40,019
I think there's a lot of value

604
00:22:40,474 --> 00:22:43,434
in good clinical care and education that makes

605
00:22:43,434 --> 00:22:45,835
up for the dollars and the cents. It's

606
00:22:45,835 --> 00:22:48,315
harder to do, takes more resources, and you've

607
00:22:48,315 --> 00:22:49,615
gotta be able to engage.

608
00:22:50,154 --> 00:22:52,394
But I I don't I don't think that's,

609
00:22:52,634 --> 00:22:54,419
I think that's the answer. I think that's,

610
00:22:54,740 --> 00:22:56,339
that's one of the levers that we're gonna

611
00:22:56,339 --> 00:22:57,159
have to develop.

612
00:22:58,339 --> 00:22:58,839
Fantastic.

613
00:22:59,299 --> 00:23:00,839
Really great insights. Cronos,

614
00:23:01,220 --> 00:23:03,379
really appreciate you taking the time to sit

615
00:23:03,379 --> 00:23:05,379
down with us and for sharing your insights

616
00:23:05,379 --> 00:23:08,234
with our listeners. We truly appreciate it. Thank

617
00:23:08,234 --> 00:23:10,075
you, Jacob. If you'd like to listen to

618
00:23:10,075 --> 00:23:12,154
more podcasts from Becker's Health Care, you can

619
00:23:12,154 --> 00:23:12,974
visit beckershospitalreview.com.